ResearcherUniversity of PaviaActive in the last 2 years
Amelia Barcellini
Matched on ORCID iD 0000-0002-1595-104X; OpenAlex author ID A5077697642. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 3 papers · 2023: none · 2024: 1 paper
Papers 7
- Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936). Co-author DOI 10.1177/03008916241291341↗
- Time-resolved MRI for off-line treatment robustness evaluation in carbon-ion radiotherapy of pancreatic cancer. Co-author DOI 10.1002/mp.15510↗
- The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer. Co-author DOI 10.1016/j.radonc.2022.09.005↗
- Factors released by low and high-LET irradiated fibroblasts modulate migration and invasiveness of pancreatic cancer cells. First author DOI 10.3389/fonc.2022.1003494↗
- Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? Co-author DOI 10.1016/j.pan.2020.05.007↗
- Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress. Co-author DOI 10.2147/ott.s220971↗
- Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, mul… Co-author DOI 10.1186/s12885-019-6108-0↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Viviana Vitolo · 6 shared papers, 2019–2024 · strength 0.80
- Paper Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (N… DOI 10.1177/03008916241291341↗
- Paper The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer. DOI 10.1016/j.radonc.2022.09.005↗
- Paper Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress. DOI 10.2147/ott.s220971↗
- Ester M. Orlandi · 5 shared papers, 2020–2024 · strength 0.74
- Paper Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (N… DOI 10.1177/03008916241291341↗
- Paper Factors released by low and high-LET irradiated fibroblasts modulate migration and invasiveness of pancreatic cancer ce… DOI 10.3389/fonc.2022.1003494↗
- Paper The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer. DOI 10.1016/j.radonc.2022.09.005↗
- Silvia Molinelli · 4 shared papers, 2019–2024 · strength 0.55
- Paper Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (N… DOI 10.1177/03008916241291341↗
- Paper The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer. DOI 10.1016/j.radonc.2022.09.005↗
- Paper Time-resolved MRI for off-line treatment robustness evaluation in carbon-ion radiotherapy of pancreatic cancer. DOI 10.1002/mp.15510↗
- Mario Ciocca · 3 shared papers, 2022 · strength 0.45
- Paper Factors released by low and high-LET irradiated fibroblasts modulate migration and invasiveness of pancreatic cancer ce… DOI 10.3389/fonc.2022.1003494↗
- Paper The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer. DOI 10.1016/j.radonc.2022.09.005↗
- Paper Time-resolved MRI for off-line treatment robustness evaluation in carbon-ion radiotherapy of pancreatic cancer. DOI 10.1002/mp.15510↗
- Angelica Facoetti · 3 shared papers, 2019–2024 · strength 0.43
- Paper Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (N… DOI 10.1177/03008916241291341↗
- Paper Factors released by low and high-LET irradiated fibroblasts modulate migration and invasiveness of pancreatic cancer ce… DOI 10.3389/fonc.2022.1003494↗
- Paper Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic aden… DOI 10.1186/s12885-019-6108-0↗
- Francesca Valvo · 3 shared papers, 2019–2024 · strength 0.36
- Paper Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (N… DOI 10.1177/03008916241291341↗
- Paper Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? DOI 10.1016/j.pan.2020.05.007↗
- Paper Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic aden… DOI 10.1186/s12885-019-6108-0↗
- Lorenzo Cobianchi · 3 shared papers, 2019–2020 · strength 0.33
- Paper Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress. DOI 10.2147/ott.s220971↗
- Paper Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? DOI 10.1016/j.pan.2020.05.007↗
- Paper Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic aden… DOI 10.1186/s12885-019-6108-0↗
- Giorgia Meschini · 2 shared papers, 2022 · strength 0.29
- Chiara Paganelli · 2 shared papers, 2022 · strength 0.29
- Giovanni Butturini · 1 shared paper, 2024 · strength 0.18
- Alexandra Charalampopoulou · 1 shared paper, 2022 · strength 0.16
- Roberto Orecchia · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.